TJ Madsen is among the founding members of the New Herald Tribune and chairs the editorial board. He worked for national syndicated newspapers in Newark, Philadelphia, and Baltimore before moving to the midwest.
November 8 , 2025
Cold Spring Harbor, NY — In a move that has sparked both fascination and debate across the scientific community, Cold Spring Harbor Laboratory (CSHL) announced on Friday that it intends to initiate a research project aimed at cloning Dr. James D. Watson, the Nobel Prize–winning co-discoverer of the DNA double-helix structure.
According to a press release issued by the laboratory, the initiative—tentatively named Project Helix Redux—is being framed as a “proof-of-concept exploration into the potential of human somatic cell cloning for historical, educational, and biomedical research.”
“This project seeks to examine how genetic identity intersects with intellectual legacy,” said Dr. Laura Kim, the project’s principal investigator, at a press briefing. “Dr. Watson’s genome is among the most extensively studied in modern science. This makes him a unique candidate for investigating how genetics and environment shape cognitive development and scientific creativity.”
CSHL officials emphasized that the project would be conducted under “strict ethical and regulatory oversight” and would not involve the creation of a cloned human embryo intended for gestation “under current legal and moral frameworks.” Instead, early stages will focus on producing and studying cloned stem cells and embryoid structures in vitro.
Dr. Watson recently died at 97 years old. CSHL confirmed that the laboratory obtained the necessary genetic material with his prior consent.
Cold Spring Harbor Laboratory, founded in 1890, has been a focal point of genetic and molecular biology research for more than a century—and was once directed by Watson himself. The proposed cloning study, pending institutional review and federal approval, could begin preliminary phases as early as mid-2026.
Copyright © 2026. All rights reserved.